Navigation Links
OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
Date:4/9/2009

BOTHELL, WA, and VANCOUVER, April 9 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI), announced today that it has been named the 2009 Life Sciences Company of the Year by LifeSciences British Columbia. This annual award is presented by LifeSciences British Columbia to recognize a local organization that has made outstanding contributions to the development of British Columbia's life sciences industry. This award recognizes a company for execution of business strategies, scientific excellence, leadership and vision and market position/opportunity. The organization also uses this award to increase public awareness and understanding of life sciences in the province.

"We are very pleased to be recognized for this award, especially in light of what was a particularly challenging economic environment in 2008," said Scott Cormack, President and CEO of OncoGenex. "For OncoGenex, 2008 was a tremendously active year as we took measures to prepare for the final stages of clinical development of our lead product candidate, OGX-011, for the treatment of cancer. We released Phase 2 clinical data showing a survival benefit in patients treated with OGX-011 and are working closely with the FDA to develop Phase 3 study designs and protocols defining a registration path for product approval. We also took measures to extend our cash runway, and we have been advancing discussions with potential development partners."

"There is no greater honour than to be recognized by one's peers," added Cormack. "I'd like to thank all the employees at OncoGenex, as this award was earned by each and every one of them through their dedication, hard work and loyalty."

About LifeSciences British Columbia

LifeSciences British Columbia supports and represents the biopharmaceutical, medical device, biopro
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015  University of Illinois, ... deliver the plenary session address on Monday, May 18 ... (IMS) , kicking off a week of more than ... intersection of RF and microwave technologies with health. ... Sensors and Circuits for the Skin," will focus on ...
(Date:3/30/2015)... 30, 2015 With recent advancements in ... the government, major companies are getting into the Solar ... future mandates for renewable energy production, many homeowners are ... Solara Power is a new solar distribution company in ... that allow qualifying homeowners to enjoy the benefits of ...
(Date:3/30/2015)... 2015  New Jersey Health Foundation, a not-for-profit organization ... of New Jersey , has committed ... announced James M. Golubieski , president. ... program, an additional $500,000 will be available for awards ... research projects that demonstrate exciting potential and may lead ...
(Date:3/30/2015)... Md. , March 30, 2015  Spherix ... company committed to the fostering and monetization of ... v. VTech,  Case No. 3:13-cv-03494-M and  Spherix v. ... United States District Court for the Northern District ... update regarding Spherix v. Verizon, Case ...
Breaking Biology Technology:Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3Solara Power Announces Residential Solar Power with No Up-Front Fees 2New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... has found that a currently available yet underused vaccine against ... unvaccinated neighbors of vaccinees. The study, conducted by ... Institute of Cholera and Enteric Diseases (NICED) in Kolkata, India, ... New England Journal of Medicine (NEJM). The IVI, based ...
... , LYNBROOK, N.Y., July 22 BioSpecifics Technologies ... in class collagenase-based products, today announced that BioSpecifics, President, Tom Wegman, ... Conference on Wednesday, July 29, 2009, at 9:30am CT at the ... A live webcast of the presentation can be accessed under ...
... July 22 Sirnaomics, Inc. (www.sirnaomics.com) announced today ... business innovation research) grant from National Cancer Institute ... novel siRNA therapeutics to treat lung cancer. Sirnaomics, ... is dedicated to advancing RNA interference (RNAi) Technology ...
Cached Biology Technology:Vi typhoid vaccine proves highly effective in young children 2Vi typhoid vaccine proves highly effective in young children 3Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics 3
(Date:3/31/2015)... 2015  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ... Software Defined Network Architecture (ET Software DNA® 2.0) platforms ... approximately $20.4 million for the year ended December 31, ... the year ended December 31, 2013. ... completed its multi-year transition away from its legacy landline ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... the "Global Gesture Recognition Market in Automotive Sector ... analysts forecast the Global Gesture Recognition market in Automotive ... the period 2013-2018. Gesture recognition is the ... different gestures of an individual. Gesture recognition technology can ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... grow replacement bones with stem cell technology, thanks to research ... Many scientists are currently trying to create bone-like materials, ... damaged or fractured bones, or who have had parts of ... materials could be inserted into cavities so that real bone ...
... WASHINGTON, DC U.S. Secretary of Energy Steven ... 46 of the 100 awards given out this year ... with promising commercial potential. The coveted awards are ... materials or software developed throughout the world and introduced ...
... bad-tasting and potentially poisonous foods may also play a role ... study by scientists at the University of Iowa Roy J. ... help explain why injured lungs are susceptible to further damage. ... Express, shows that receptors for bitter compounds that are ...
Cached Biology News:Scientists closer to making implantable bone material, thanks to new research 2DOE-funded research projects win 46 R&D 100 Awards for 2009 2DOE-funded research projects win 46 R&D 100 Awards for 2009 3DOE-funded research projects win 46 R&D 100 Awards for 2009 4DOE-funded research projects win 46 R&D 100 Awards for 2009 5DOE-funded research projects win 46 R&D 100 Awards for 2009 6DOE-funded research projects win 46 R&D 100 Awards for 2009 7DOE-funded research projects win 46 R&D 100 Awards for 2009 8DOE-funded research projects win 46 R&D 100 Awards for 2009 9DOE-funded research projects win 46 R&D 100 Awards for 2009 10DOE-funded research projects win 46 R&D 100 Awards for 2009 11DOE-funded research projects win 46 R&D 100 Awards for 2009 12DOE-funded research projects win 46 R&D 100 Awards for 2009 13DOE-funded research projects win 46 R&D 100 Awards for 2009 14Airway cells use 'tasting' mechanism to detect and clear harmful substances 2
...
Mouse monoclonal [CRC64] to Integrin alpha 2b + beta 3 ( Abpromise for all tested applications). Antigen: Human platelets Entrez Gene ID: 23295 Swiss Protein ID: P05106...
This antibody detects cdc42 on SDS-PAGE immunoblots....
Goat anti-PITPN Class: Antibody Product Group: Miscellaneous Antibody...
Biology Products: